Probing the size of a hydrophobic binding pocket within the allosteric site of muscarinic acetylcholine M2-receptors

被引:26
作者
Bender, W
Staudt, M
Tränkle, C
Mohr, K
Holzgrabe, U
机构
[1] Univ Wurzburg, Inst Pharm, Dept Pharmaceut Chem, D-97074 Wurzburg, Germany
[2] Univ Bonn, Inst Pharm, Dept Pharmacol & Toxicol, D-53121 Bonn, Germany
关键词
alkane bisammonium compounds; allosteric modulation; M-2 acetylcholine receptors; quantitative structure-activity relationships;
D O I
10.1016/S0024-3205(00)00490-2
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Hexane-bisammonium-type compounds containing lateral phthalimide moieties are known to have a rather high affinity for the allosteric site of muscarinic M-2 receptors. In order to get more insight into the contribution of the lateral substituents for alloster binding affinity, a series of compounds with unilaterally varying imide substituents were synthesized and tested for their ability to retard allosterically the dissociation of [H-3]N-methylscopolamine fi om the receptor protein (control t(1/2) = 2 min; 3 mM MgHCO4, 50 mM Tris, pH 7.3, 37 degrees C). Among the test compounds, the naphthalimide containing agent (half maximum effect at EC50,diss = 60 nM) revealed the highest potency. Apparently, its affinity for the allosteric site in NMS-occupied receptors is 20fold higher compared with the phthalimide containing parent compound W 84. Analysis of quantitative structure-activity relationships yielded a parabolic correlation between the volume of the lateral substituents and the allosteric potency. The maximal volume was determined to be approximately 600 Angstrom(3) suggesting that the allosteric binding site contains a binding pocket of a defined size for the imide moiety.
引用
收藏
页码:1675 / 1682
页数:8
相关论文
共 20 条
[11]  
Kubinyi H., 1993, METHODS PRINCIPLES M, DOI DOI 10.1002/9783527616824
[12]  
KUBINYI H, 1997, 67056 BASF AG
[13]  
LAZARENO S, 1995, MOL PHARMACOL, V48, P362
[14]   Bisquaternary ligands of the common allosteric site of M2 acetylcholine receptors:: Search for the minimum essential distances between the pharmacophoric elements [J].
Nassif-Makki, T ;
Tränkle, C ;
Zlotos, D ;
Bejeuhr, G ;
Cambareri, A ;
Pfletschinger, C ;
Kostenis, E ;
Mohr, K ;
Holzgrabe, U .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (05) :849-858
[15]  
PROSKA J, 1998, MOL PHARMACOL, V45, P709
[16]   Contribution of lateral substituents in heptane-bisammonium derivatives to the allosteric stabilization of antagonist binding to M2-receptors [J].
Staudt, M ;
Tränkle, C ;
Mohr, K ;
Holzgrabe, U .
LIFE SCIENCES, 1997, 62 (05) :423-429
[17]  
Trankle C, 1996, J PHARMACOL EXP THER, V279, P926
[18]   Identification of a [3H]ligand for the common allosteric site of muscarinic acetylcholine M2 receptors [J].
Tränkle, C ;
Mies-Klomfass, E ;
Cid, MHB ;
Holzgrabe, U ;
Mohr, K .
MOLECULAR PHARMACOLOGY, 1998, 54 (01) :139-145
[19]   ALLOSTERIC MODULATION OF MUSCARINIC ACETYLCHOLINE-RECEPTORS [J].
TUCEK, S ;
PROSKA, J .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1995, 16 (06) :205-212
[20]   EFFECTS OF D-TUBOCURARINE ON RAT CARDIAC MUSCARINIC RECEPTORS - A COMPARISON WITH GALLAMINE [J].
WAELBROECK, M ;
ROBBERECHT, P ;
DENEEF, P ;
CHRISTOPHE, J .
JOURNAL OF RECEPTOR RESEARCH, 1988, 8 (06) :787-808